Unnamed: 0,title,date,stock,sentiment
306201.0,61 Stocks Moving In Wednesday's Mid-Day Session,2020-06-10 13:31:00-04:00,CSII,neutral
306202.0,Cardiovascular Systems shares are trading lower after the company announced a common stock offering of 3.6 million shares at $34 per share.,2020-06-10 07:49:00-04:00,CSII,positive
306203.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-06-10 07:35:00-04:00,CSII,neutral
306204.0,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",2020-06-10 07:30:00-04:00,CSII,positive
306205.0,34 Stocks Moving in Wednesday's Pre-Market Session,2020-06-10 07:17:00-04:00,CSII,neutral
306206.0,Cardiovascular Systems Prices 3.6M Share Public Offering of Common Stock @$34/Share,2020-06-10 06:19:00-04:00,CSII,positive
306207.0,Cardiovascular Systems Reports $125M Common Stock Offering,2020-06-09 16:10:00-04:00,CSII,neutral
306208.0,"Cardiovascular Systems Q3 EPS $(0.080), Inline, Sales $61.200M Miss $65.800M Estimate",2020-05-05 16:21:00-04:00,CSII,negative
306209.0,"The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout",2020-05-05 08:00:00-04:00,CSII,positive
306210.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,CSII,neutral
306211.0,"SVB Leerink Maintains Outperform on Cardiovascular Systems, Lowers Price Target to $50",2020-04-28 12:02:00-04:00,CSII,negative
306212.0,"Benzinga's Top Upgrades, Downgrades For April 7, 2020",2020-04-07 09:41:00-04:00,CSII,positive
306213.0,"Oppenheimer Initiates Coverage On Cardiovascular Systems with Outperform Rating, Announces Price Target to $47",2020-04-07 05:24:00-04:00,CSII,neutral
306214.0,"Cardiovascular Systems 8-K Shows Deal With Fresenius Kabi To Be Extended For Added 44 Months To Dec. 31, 2024",2020-03-20 09:14:00-04:00,CSII,neutral
306215.0,100 Biggest Movers From Yesterday,2020-02-07 04:30:00-05:00,CSII,neutral
306216.0,74 Stocks Moving In Thursday's Mid-Day Session,2020-02-06 12:38:00-05:00,CSII,neutral
306217.0,"The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs",2020-02-06 07:47:00-05:00,CSII,negative
306218.0,Cardiovascular SystemsRaises Low End Of FY20 Sales Guidance From $280M to $283M Vs $280.7M Estimate,2020-02-05 16:17:00-05:00,CSII,negative
306219.0,"Cardiovascular Systems Q2 EPS $(0.1) Misses $(0.01) Estimate, Sales $68.3M Beat $68.02M Estimate",2020-02-05 16:15:00-05:00,CSII,negative
306220.0,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",2020-02-05 07:43:00-05:00,CSII,neutral
306221.0,"The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus",2020-02-02 13:04:00-05:00,CSII,neutral
306222.0,"The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment",2020-01-23 07:24:00-05:00,CSII,positive
306223.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-22 10:17:00-05:00,CSII,neutral
306224.0,"The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings",2020-01-22 08:25:00-05:00,CSII,neutral
306225.0,Stocks That Hit 52-Week Highs On Tuesday,2020-01-21 10:11:00-05:00,CSII,neutral
306226.0,Stocks That Hit 52-Week Highs On Friday,2020-01-17 13:23:00-05:00,CSII,neutral
306227.0,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",2019-10-30 07:01:00-04:00,CSII,negative
306228.0,Cardiovascular Systems shares are trading lower after the company reported worse-than-expected Q1 EPS results.,2019-10-29 17:11:00-04:00,CSII,neutral
306229.0,"Cardiovascular Systems Q1 EPS $(0.17) Misses $(0.08) Estimate, Sales $64.5M Beat $63.87M Estimate",2019-10-29 16:13:00-04:00,CSII,negative
306230.0,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study",2019-10-29 07:32:00-04:00,CSII,positive
306231.0,Cardiovascular Systems Option Alert: Nov 15 $50 Calls Sweep (3) near the Ask: 730 @ $1.851 vs 32 OI; Earnings 10/29 After Close Ref=$47.425,2019-10-28 11:18:00-04:00,CSII,positive
306232.0,"Benzinga's Top Upgrades, Downgrades For October 18, 2019",2019-10-18 09:53:00-04:00,CSII,positive
306233.0,"Guggenheim Initiates Coverage On Cardiovascular Systems with Buy Rating, Announces $58 Price Target",2019-10-18 06:11:00-04:00,CSII,neutral
306234.0,"Cardiovascular Systems, Inc. Announces FDA Approval Of The Coronary ViperWire Advance With Flex Tip",2019-09-24 07:10:00-04:00,CSII,positive
306235.0,"The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts",2019-09-18 07:39:00-04:00,CSII,neutral
306236.0,Stocks That Hit 52-Week Highs On Tuesday,2019-09-17 10:40:00-04:00,CSII,neutral
306237.0,Stocks That Hit 52-Week Highs On Friday,2019-09-13 14:58:00-04:00,CSII,neutral
306238.0,"The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study",2019-08-22 07:18:00-04:00,CSII,positive
306239.0,Stocks That Hit 52-Week Highs On Wednesday,2019-08-21 10:17:00-04:00,CSII,neutral
306240.0,Stocks That Hit 52-Week Highs On Tuesday,2019-08-20 10:27:00-04:00,CSII,neutral
306241.0,"The Daily Biotech Pulse: FDA Likes Nabriva's Antibiotic, Snubs Sarepta's DMD Drug; Moderna Gets Fast Track Designation For Zika Vaccine",2019-08-20 07:33:00-04:00,CSII,negative
306242.0,"Cardiovascular Systems Q4 EPS $0.04, Inline, Sales $68.234M Beat $66.14M Estimate",2019-08-06 16:24:00-04:00,CSII,neutral
306243.0,Cardiovascular Systems Acquires Gardia Medical's WIRION Embolic Protection System; Financial Terms Not Disclosed,2019-08-06 03:50:00-04:00,CSII,neutral
306244.0,"The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug",2019-07-25 07:21:00-04:00,CSII,negative
306245.0,"Benzinga's Top Upgrades, Downgrades For July 17, 2019",2019-07-17 09:16:00-04:00,CSII,positive
306246.0,"Stifel Nicolaus Downgrades Cardiovascular Systems to Hold, Raises Price Target to $45",2019-07-17 06:40:00-04:00,CSII,neutral
306247.0,"The Daily Biotech Pulse: Positive Readouts From Adamas And Ironwood, Sesen Bio To Offer Shares, Stoke Therapeutics Debut",2019-06-19 07:51:00-04:00,CSII,positive
306248.0,Cardiovascular Systems Announces FY19 Revenue Guidance Of $245-247M Vs. $245.22M Estimate,2019-05-01 17:42:00-04:00,CSII,neutral
306249.0,"Cardiovascular Systems Q3 EPS $0.02 Beats $(0.03) Estimate, Sales $63.311M Beat $62.85M Estimate",2019-05-01 17:40:00-04:00,CSII,neutral
306250.0,"The Daily Biotech Pulse: Zafgen Won't File IND For Metabolic Disorder Drug, Positive Results For Akebia's Anemia Drug",2019-03-12 07:47:00-04:00,CSII,positive
306251.0,62 Biggest Movers From Yesterday,2019-03-05 05:19:00-05:00,CSII,neutral
306252.0,50 Stocks Moving In Monday's Mid-Day Session,2019-03-04 12:44:00-05:00,CSII,neutral
306253.0,Cardiovascular systems shares are trading higher after S&P Dow Jones Indices announced the company will replace Nutrisystem in the S&P SmallCap 600.,2019-03-04 09:05:00-05:00,CSII,positive
306254.0,"Cardiovascular Systems Q2 EPS $0.01 Beats $(0.04) Estimate, Sales $60.2M Beat $59.44M Estimate",2019-01-30 16:24:00-05:00,CSII,neutral
306255.0,Cardiovascular Systems Reports First Patients In Middle East Treated With Co.'s Diamondback 360 Coronary Orbital Atherectomy System,2019-01-16 16:09:00-05:00,CSII,neutral
306256.0,Cardiovascular Systems Narrows FY2019 Sales Guidance from $240.0M-250.0M to $243.0M-247.0M vs $244.72M Est,2019-01-07 07:02:00-05:00,CSII,neutral
306257.0,Cardiovascular Systems Sees Q2 Sales $60.20M vs $59.19M Est,2019-01-07 07:01:00-05:00,CSII,neutral
306258.0,"Cardiovascular Systems, Inc. Receives Approval For Diamondback 360 Coronary Orbital Atherectomy System With Classic Crown And New ViperWire Advance FlexTip Guidewire In Japan",2019-01-02 07:22:00-05:00,CSII,positive
306259.0,"Cardiovascular Systems, Inc. Announces First US Patients Treated With OrbusNeich Teleport Microcatheter",2018-12-26 16:05:00-05:00,CSII,neutral
306260.0,Cardiovascular Systems S-3 Shows Registration For $350M Mixed Securities Offering,2018-12-06 16:15:00-05:00,CSII,positive
306261.0,Cardiovasular Systems Announces a First Patient in Hong Kong is Treated,2018-11-08 08:47:00-05:00,CSII,neutral
306262.0,82 Biggest Movers From Yesterday,2018-11-01 04:38:00-04:00,CSII,neutral
306263.0,66 Stocks Moving In Wednesday's Mid-Day Session,2018-10-31 12:50:00-04:00,CSII,neutral
306264.0,Cardiovascular Systems Maintains FY2019 Sales Guidance of $240.0M-250.0M vs $244.36M Est,2018-10-30 16:52:00-04:00,CSII,neutral
306265.0,"Cardiovascular Systems, Inc. Q1 EPS $(0.09) Misses $(0.05) Estimate, Sales $56.3M Beat $55.48M Estimate",2018-10-30 16:49:00-04:00,CSII,negative
306266.0,"Stocks Which Set New 52-Week High Friday, September 14th",2018-09-17 09:28:00-04:00,CSII,neutral
306267.0,"Benzinga's Top Upgrades, Downgrades For August 22, 2018",2018-08-22 09:16:00-04:00,CSII,positive
306268.0,"Stifel Nicolaus Initiates Coverage On Cardiovascular Systems with Buy Rating, Announces $45 Price Target",2018-08-22 07:06:00-04:00,CSII,neutral
306269.0,"Stocks Which Set New 52-Week High Yesterday, July 31",2018-08-01 12:04:00-04:00,CSII,neutral
306270.0,"Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial",2018-08-01 09:01:00-04:00,CSII,negative
306271.0,65 Biggest Movers From Yesterday,2018-08-01 04:36:00-04:00,CSII,neutral
306272.0,52 Stocks Moving In Tuesday's Mid-Day Session,2018-07-31 12:38:00-04:00,CSII,neutral
306273.0,Cardiovascular Systems Shares Up 12% After Announcement Co. Has Signed Collaborative Agreement For Laser Atherectomy Technology With Aerolase Corp.,2018-07-31 11:42:00-04:00,CSII,positive
306274.0,"Cardiovascular Systems, Inc. And Aerolase Corp. Sign Collaborative Agreement For Laser Atherectomy Technology",2018-07-31 08:00:00-04:00,CSII,positive
306275.0,Cardiovascular Systems Holding Analyst/Investor Day Today,2018-07-31 06:34:00-04:00,CSII,neutral
306276.0,Cardiovascular Systems Sees FY19 Sales $240M-$250M vs $239.77M Est.,2018-07-30 16:30:00-04:00,CSII,neutral
306277.0,"Cardiovascular Systems Q4 EPS $0.11 Beats $0.06 Estimate, Sales $59.152M Beat $58.23M Estimate",2018-07-30 16:29:00-04:00,CSII,neutral
306278.0,"The Week Ahead: Apple And Tesla Earnings, FOMC Meeting, Sonos IPO",2018-07-30 13:46:00-04:00,CSII,neutral
306279.0,Stocks Which Set New 52-Week Highs Friday,2018-07-23 11:08:00-04:00,CSII,neutral
306280.0,Stocks Which Set New 52-Week High Yesterday,2018-07-20 09:05:00-04:00,CSII,neutral
306281.0,"Cardiovascular Systems, Inc. Signs International Distribution Agreement With OrbusNeich To Sell Its Peripheral Orbital Atherectomy Systems  Outside The US And Japan",2018-07-16 16:06:00-04:00,CSII,positive
306282.0,"Benzinga's Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut",2018-06-28 08:26:00-04:00,CSII,positive
306283.0,42 Biggest Movers From Yesterday,2018-06-28 05:44:00-04:00,CSII,neutral
306284.0,40 Stocks Moving In Wednesday's Mid-Day Session,2018-06-27 13:04:00-04:00,CSII,neutral
306285.0,55 Biggest Movers From Yesterday,2018-05-04 04:41:00-04:00,CSII,neutral
306286.0,"Cardiovascular Systems Sees Q4 Sales $57.5-$59M vs $58.38M Est., EPS $0.05-$0.08 vs $0.03 Est.",2018-05-02 17:37:00-04:00,CSII,neutral
306287.0,"Cardiovascular Systems Q3 EPS $0.01 Beats $(0.02) Estimate, Sales $55.587M Miss $55.72M Estimate",2018-05-02 17:37:00-04:00,CSII,negative
306288.0,Cardiovascular Systems Earnings Preview,2018-05-02 07:33:00-04:00,CSII,neutral
306289.0,"Cardiovascular Systems, Inc. and OrbusNeich Announce FDA Clearance of the First and Only 1.0mm Coronary Balloon in the U.S.",2018-03-01 14:38:00-05:00,CSII,neutral
306290.0,Cardiovascular Systems Cuts FY18 Sales Guidance From $226M-$233M to $215M-$219M vs $224M Est.,2018-02-07 16:34:00-05:00,CSII,negative
306291.0,"Cardiovascular Systems Reports Q2 EPS $(0.01) vs $(0.04) Est., Sales $52.6M vs $53.4M Est.",2018-02-07 16:33:00-05:00,CSII,neutral
306292.0,Cardiovascular Systems Names Jeff Points CFO,2018-02-07 16:23:00-05:00,CSII,neutral
306293.0,Cardiovascular Systems Announces Commercial Launch In Japan,2018-02-01 16:26:00-05:00,CSII,neutral
306294.0,Cardiovascular Systems Names Rhonda Robb COO,2018-01-24 06:18:00-05:00,CSII,neutral
306295.0,Cardiovascular Systems Announces 2 Partnerships to Broaden its Product Portfolio,2018-01-18 07:04:00-05:00,CSII,neutral
306296.0,"Benzinga's Top Upgrades, Downgrades For December 15, 2017",2017-12-15 08:57:00-05:00,CSII,positive
306297.0,Needham Downgrades Cardiovascular Systems to Hold,2017-12-15 08:39:00-05:00,CSII,neutral
306298.0,"Cardiovascular Systems Sees Q2 Sales $52.5-$54M vs $54.9M Est., EPS $(0.06)-$(0.03) vs $(0.01) Est.; FY18 Sales $226-$223M vs $227M Est.",2017-10-25 16:32:00-04:00,CSII,neutral
306299.0,"Cardiovascular Systems Reports Q1 EPS $(0.06) vs $(0.07) Est., Sales $49.67M vs $51M Est.",2017-10-25 16:31:00-04:00,CSII,neutral
306300.0,28 Stocks Moving In Monday's Pre-Market Session,2017-10-16 08:17:00-04:00,CSII,neutral
306301.0,Raymond James Initiates Coverage On Cardiovascular Systems with Market Perform Rating,2017-09-22 08:10:00-04:00,CSII,neutral
306302.0,Cardiovascular Systems Expects Q1 Sales Impact from Hurricanes Harvey and Irma to Range From $52.6M to $53.6M,2017-09-18 07:12:00-04:00,CSII,neutral
306303.0,"Cardiovascular Systems Reports Q4 EPS $0.02 vs $(0.15) in Same Qtr. Last Year, Sales $52.9M",2017-08-02 17:59:00-04:00,CSII,neutral
306304.0,13G Filing From Brown Capital On Cardivascular Systems Shows 7.56% Stake,2017-07-10 14:48:00-04:00,CSII,neutral
306305.0,Hearing Bank of America Downgrades Cardiovascular Systems to Underperform,2017-06-21 10:38:00-04:00,CSII,neutral
306307.0,"Cardiovascular Systems Innovation On Track, Competition Rife",2017-06-07 13:56:00-04:00,CSII,positive
306308.0,"Wall Street's M&A Chatter From May 10: Abercrombie & Fitch, Calpine, Sprint-T-Mobile",2017-05-11 07:24:00-04:00,CSII,neutral
306309.0,"Spectranetics, Cardiovascular Shares Spike to Session Highs as Traders Circulating Alert from CTFN M&A Reporting",2017-05-10 11:50:00-04:00,CSII,positive
306310.0,Cardiovascular Systems Announces FDa Approves Premarket Approval Application For Saline Infusion Pump,2017-05-04 12:50:00-04:00,CSII,positive
306311.0,"Cardiovascular Systems Reports Q3 EPS $(0.05) In-line With Est., Sales $52.1M vs $51.13M Est.",2017-05-03 17:24:00-04:00,CSII,neutral
306312.0,"UPDATE: Cardiovascular Says on Apr. 25, 2017 Jury Awarded Steven Babyak $22.4M in Punitive Damages with Respect to claims Awarded on Apr. 24",2017-04-26 09:12:00-04:00,CSII,positive
306313.0,"8-K from Cardiovascular Systems Shows Jury Awarded Steven Babyak $2.7M in Compensatory Damages Related to Claims for Whistleblower Retaliation, Wrongful Termination in Violation of Public Policy",2017-04-26 09:08:00-04:00,CSII,negative
306314.0,"Cardiovascular Systems Shares Down 2.5% Following News Late Monday of Voluntary Recall of Saline Infusion Pump; Co. Sees Recording ~$1.5M Expense in Q3 Related to Recall, Replacement",2017-04-18 12:02:00-04:00,CSII,positive
306315.0,Cardiovascular Systems Shares Halted News Pending,2017-04-17 18:04:00-04:00,CSII,positive
306316.0,"Cardiovascular Systems, Inc. Secures $40M Line of Credit from Silicon Valley Bank",2017-04-04 09:03:00-04:00,CSII,positive
306317.0,"Cardiovascular Sees Q3 EPS $(0.06)-$(0.04) vs $(0.05) Est., Sales $50.5M-$51.5M vs $51.9M Est.",2017-01-25 16:14:00-05:00,CSII,neutral
306318.0,"Cardiovascular Systems Reports Q2 EPS $0.03 vs $(0.06) Est., Sales $50.043M vs $49.5M Est.",2017-01-25 16:13:00-05:00,CSII,neutral
306319.0,"10 Stocks That Rallied Four Days, Then Sold Off Yesterday",2016-12-12 05:32:00-05:00,CSII,neutral
306320.0,"Cardiobascular Systems Signs Exclusive Japanese Distribution Agreement with Medikit, Will Recieve $10M Up Front Payment",2016-11-14 06:08:00-05:00,CSII,positive
306321.0,Cardiovascular Systems Signs Distribution Agreement With Medikit for Japan; Agreement Includes $10M Upfront Payment to Cardiovascular Systems,2016-11-14 06:03:00-05:00,CSII,positive
306322.0,Medikit Secures Exclusive Distribution Right of Calcific Lesions Treatment Device from Cardiovascular Systems in Japan Market,2016-11-11 04:12:00-05:00,CSII,positive
306323.0,Mid-Morning Market Update: Markets Open Higher; Twitter Beats Q3 Expectations,2016-10-27 10:09:00-04:00,CSII,neutral
306324.0,"Cardiovascular Sees Q2 Rev. $49-$50M vs. Est. $49.5M, EPS $(0.07)-$(0.05) vs. Est. $(0.17)",2016-10-26 16:55:00-04:00,CSII,neutral
306325.0,"Cardiovascular Systems Reports Q1 EPS $(0.06) vs. Est. $(0.19), Rev. $49.8M vs. Est. 49M",2016-10-26 16:54:00-04:00,CSII,neutral
306326.0,10 Biggest Mid-Day Gainers For Monday,2016-08-22 13:24:00-04:00,CSII,neutral
306327.0,Benzinga's Top Upgrades,2016-08-22 09:50:00-04:00,CSII,positive
306328.0,Leerink Swann Upgrades Cardiovascular Systems to Outperform,2016-08-22 07:23:00-04:00,CSII,neutral
306329.0,"Cardiovascular Systems Announces Scott Ward CEO, Has Been Interim CEO",2016-08-16 07:03:00-04:00,CSII,neutral
306330.0,Cardiovascular Systems Reports Results from Liberty 360 Study in Presentation at AMP: 'Data shows high freedom from MAE rates across all Rutherford classes...',2016-08-11 10:31:00-04:00,CSII,positive
306331.0,Bank of America Upgrades Cardiovascular Systems to Neutral,2016-08-04 06:49:00-04:00,CSII,neutral
306332.0,"Cardiovascular Systems Sees Q1 Rev. $48-$49.5M vs. Est. $45M, EPS $(0.21)-$(0.18) vs. Est. $(0.22)",2016-08-03 16:55:00-04:00,CSII,neutral
306333.0,"Cardiovascular Systems Reports Q4 EPS $(0.15) vs. Est. $(0.20), Rev. $48.5M vs. Est. $46M",2016-08-03 16:54:00-04:00,CSII,neutral
306334.0,BMO Capital Highlights This Week's MedTech Earnings,2016-08-01 15:14:00-04:00,CSII,neutral
306335.0,Cardiovascular Systems Reports Submission of Diamondback 360 Coronary Orbital Atherectomy System Micro Crown for Approval in Japan,2016-07-06 16:05:00-04:00,CSII,positive
306336.0,"Cardiovascular Sees Q4 Sales $45M-$46.5M vs $43.3M Est., EPS $(0.21)-$(0.18) vs $(0.37) Est.",2016-05-04 17:55:00-04:00,CSII,neutral
306337.0,"Cardiovascular Systems Reports Q3 EPS $(0.69) Vs Est $(0.54), Sales $44.5M Vs Est $42.13M",2016-05-04 16:27:00-04:00,CSII,neutral
306338.0,Mid-Afternoon Market Update: Crude Oil Down 3.5%; Tesla Shares Rise Following Model 3 Launch,2016-04-01 14:32:00-04:00,CSII,negative
306339.0,Mid-Day Market Update: US Stocks Turn Higher; Starwood Shares Drop Following Anbang Consoritum's Bailed Takeover,2016-04-01 12:21:00-04:00,CSII,neutral
306340.0,Benzinga's Volume Movers,2016-04-01 10:21:00-04:00,CSII,neutral
306341.0,Mid-Morning Market Update: Markets Open Lower; BlackBerry Q4 Revenue Misses Estimates,2016-04-01 10:09:00-04:00,CSII,negative
306342.0,Benzinga's Top Upgrades,2016-04-01 09:18:00-04:00,CSII,positive
306343.0,10 Stocks Moving In Friday's Pre-Market Session,2016-04-01 08:22:00-04:00,CSII,neutral
306344.0,Needham Upgrades Cardiovascular Systems to Buy,2016-04-01 08:00:00-04:00,CSII,neutral
306345.0,"Cardiovascular Systems Granted Consent Motion to Stay DoJ Action up to May 15, 2016",2016-03-21 08:38:00-04:00,CSII,positive
306346.0,"Cardisovascular Systems Names Scott Ward As Interim CEO, David Martin To Step Down For Health Reasons",2016-03-01 08:20:00-05:00,CSII,neutral
306347.0,"Cardiovascular Systems Announces CEO David Martin is Stepping Down to Focus on His Cancer Treatment; Scott Ward Will Remain Interim Pres, CEO While Co. Conducting Search for Successor",2016-02-29 16:44:00-05:00,CSII,negative
306348.0,Mid-Morning Market Update: Markets Open Lower; McDonald's Beats Q4 Estimates,2016-01-25 10:01:00-05:00,CSII,negative
306349.0,Mid-Afternoon Market Update: 8x8 Shares Rise On Upbeat Results; American Express Drops,2016-01-22 14:32:00-05:00,CSII,positive
306350.0,Mid-Day Market Update: Crude Oil Jumps 7%; Golar LNG Shares Gain on News of MoU with Schlumberger,2016-01-22 11:52:00-05:00,CSII,positive
306351.0,Stocks Hitting 52-Week Lows,2016-01-22 10:15:00-05:00,CSII,negative
306352.0,Mid-Morning Market Update: Markets Open Higher; General Electric Profit Beats Views,2016-01-22 10:05:00-05:00,CSII,positive
306353.0,Benzinga's Top Downgrades,2016-01-22 09:19:00-05:00,CSII,positive
306354.0,"Benchmark Calls Cardiovascular System Q2 Results 'disappointing', Lowers PT From $20 To $16 & Maintains Buy",2016-01-22 08:15:00-05:00,CSII,negative
306355.0,Needham Downgrades Cardiovascular Systems to Underperform,2016-01-22 07:35:00-05:00,CSII,neutral
306356.0,Why These 7 Stocks Are Moving In Thursday's After-Hours Session,2016-01-21 16:46:00-05:00,CSII,neutral
306357.0,"Cardiovascular Systems Reports Q2 EPS $(0.47) vs $(0.50) Est., Sales $41.4M vs $44.8M Est.",2016-01-21 16:07:00-05:00,CSII,neutral
306358.0,"8-K from Cardiovascular Systems Shows District Court for Western District of North Carolina, Charlotte Division Granted Motion to Extend Time to File Response to False Claims Act Complaint",2015-12-15 16:55:00-05:00,CSII,positive
306359.0,Cardiovascular Systems Announces CEO David Martin to Take Medical Leave of Absence for ~Three Months; Chair Scott Ward to Serve as Interim CEO,2015-11-16 16:45:00-05:00,CSII,negative
306360.0,Cardiovacular Reports Q1 Loss $0.41 Vs Est Loss $0.42,2015-11-04 16:24:00-05:00,CSII,negative
306361.0,Stocks Hitting 52-Week Lows,2015-10-08 10:21:00-04:00,CSII,negative
306362.0,Benzinga's Top Downgrades,2015-10-08 10:12:00-04:00,CSII,positive
306363.0,Morning Market Losers,2015-10-08 09:55:00-04:00,CSII,negative
306364.0,Leerink Downgrades Cardiovascular Systems to Market Perform,2015-10-08 07:58:00-04:00,CSII,neutral
306365.0,"Bank of America Downgrades Cardiovascular Systems to Underperform, Lowers to $15.00",2015-10-08 07:46:00-04:00,CSII,negative
306366.0,Cardiovascular Systems Reports Q1 Prelim Net Loss Of $0.43-$0.41 Vs est Loss $0.39,2015-10-07 16:02:00-04:00,CSII,negative
306367.0,Cardiovascular Systems Reports Q1 Prelim Revs $43.9M Vs Est $49.37M,2015-10-07 16:01:00-04:00,CSII,neutral
306368.0,UPDATE: Cardiovascular Systems Says CEO Dave Martin To Continue To Run Company Dispite Recent Diagnosis Of Cancer,2015-09-14 16:17:00-04:00,CSII,negative
306369.0,Cardiovascular Systems Says CEO Dave Martin To Continue To Run Company Dispite Recent Diagnosis Of Cancer; Some Activities Such As Travel May Be Limited,2015-09-14 16:16:00-04:00,CSII,negative
306370.0,"Cardiovascular Systems Reports Q4 EPS $(0.27) vs. Est. $(0.30), Rev. $48.454M vs. Est. $50.1M",2015-08-05 16:21:00-04:00,CSII,neutral
306371.0,FDA Clears Next-Generation Guide Wire for Cardiovascular Systems' Peripheral Orbital Atherectomy Systems,2015-07-06 17:00:00-04:00,CSII,positive
306372.0,"Cardiovascular Systems Earlier Reported Q3 Loss of $0.34/Share, Inline, Sales $47M; Sees Q4 Loss of $0.31-$0.28/Share",2015-04-29 17:59:00-04:00,CSII,negative
306373.0,Cardiovascular Systems Granted FDA Clearance for New Peripheral Diamondback Device,2015-04-20 07:05:00-04:00,CSII,positive
306374.0,Why JMP Securities Is Watching (And Loving) These 3 Biotech Stocks,2015-02-24 16:42:00-05:00,CSII,positive
306375.0,Cardiovascular Systems Reports Release of Two-Year ORBIT II Coronary Data,2015-02-23 16:01:00-05:00,CSII,neutral
306376.0,How To Profit From An Aging Population,2014-12-05 10:46:00-05:00,CSII,positive
306377.0,Cardiovascular Systems Announces Receiving of CE Mark for Stealth 360 Peripheral Orbital Atherectomy System,2014-11-03 10:45:00-05:00,CSII,negative
306378.0,FDA Says Cardiovascular Systems Recalled Certain Lots of Diamondback 360 Peripheral Orbital Atherectomy Systems as They May Contain Defective Saline Sheaths That Could Fracture During Use,2014-08-19 14:12:00-04:00,CSII,negative
306379.0,"Cardiovascular Systems, Inc. Reports Q4 EPS of $(0.31) vs $(0.28) Est; Revenue of $39.60M vs $37.21M Est",2014-08-06 16:25:00-04:00,CSII,neutral
306380.0,UPDATE: Bank of America Initiates Coverage On Cardiovascular Systems On Positive Outlook,2014-05-12 10:07:00-04:00,CSII,positive
306381.0,Benzinga's Top Initiations,2014-05-12 07:46:00-04:00,CSII,positive
306382.0,"Bank of America Initiates Coverage on Cardiovascular Systems, Inc. at Buy, Announces $38.00 PT",2014-05-12 07:01:00-04:00,CSII,neutral
306383.0,"Cardiovascular Systems, Inc. Sees Q4 EPS $(0.27)-(0.30) vs $(0.31) Est; Sees Sales $36.30M-37.80M vs $36.49M Est",2014-04-30 16:15:00-04:00,CSII,neutral
306384.0,"Cardiovascular Systems, Inc. Reports Q3 EPS of $(0.32), Inline; Revenue of $34.90M vs $34.15M Est",2014-04-30 16:15:00-04:00,CSII,neutral
306385.0,"Needham Initiates Coverage on Cardiovascular Systems, Inc. at Strong Buy, Announces $47.00 PT",2014-03-21 07:44:00-04:00,CSII,positive
306386.0,"Benchmark Upgrades Cardiovascular Systems, Inc. to Buy, Raises PT to $38.00",2014-01-30 07:57:00-05:00,CSII,neutral
306387.0,"Cardiovascular Systems, Inc. Sees Q3 EPS $(0.31)-(0.34) vs $(0.28) Est; Sees Sales $33.0M-34.50M vs $32.70M Est",2014-01-29 16:26:00-05:00,CSII,neutral
306388.0,"Cardiovascular Systems, Inc. Reports Q4 EPS of $(0.32) vs $(0.36) Est; Revenue of $32.30M vs $30.62M Est",2014-01-29 16:25:00-05:00,CSII,neutral
306389.0,"Wunderlich Maintains Buy on Cardiovascular Systems, Inc., Raises PT to $41.00",2014-01-10 06:25:00-05:00,CSII,neutral
306390.0,Benzinga's Top #PreMarket Gainers,2013-11-21 08:13:00-05:00,CSII,positive
306391.0,Cardiovascular Systems Prices 2.608M Share Offering at $30.00/Share,2013-11-20 19:53:00-05:00,CSII,positive
306392.0,"Wunderlich Maintains Buy on Cardiovascular Systems, Inc., Raises PT to $34.00",2013-10-31 07:00:00-04:00,CSII,neutral
306393.0,"Cardiovascular Systems, Inc. Sees Q2 EPS $(0.36)-(0.38) vs $(0.33) Est; Sees Sales $30.0M-31.0M vs $29.69M Est",2013-10-30 16:44:00-04:00,CSII,neutral
306394.0,"Cardiovascular Systems, Inc. Reports Q3 EPS of $(0.29) vs $(0.40) Est; Revenue of $29.80M vs $27.91M Est",2013-10-30 16:43:00-04:00,CSII,neutral
306395.0,"Benchmark Maintains Speculative Buy on Cardiovascular Systems, Inc., Raises PT to $35.00",2013-10-22 12:36:00-04:00,CSII,positive
306396.0,Cardiovascular Systems Receives Coronary FDA Approval ,2013-10-22 08:08:00-04:00,CSII,positive
306397.0,"Wunderlich Maintains Buy on Cardiovascular Systems, Inc., Raises PT to $30.00",2013-10-22 07:15:00-04:00,CSII,neutral
306398.0,"Cardiovascular Systems, Inc. Reports Q4 EPS of $(0.28) vs $(0.30) Est; Revenue of $28.80M vs $27.18M Est",2013-08-07 16:14:00-04:00,CSII,neutral
306399.0,UPDATE: Wunderlich Initiates Cardiovascular Systems with Buy on Positive Outlook,2013-07-26 09:18:00-04:00,CSII,positive
306400.0,Benzinga's Top Initiations,2013-07-26 08:43:00-04:00,CSII,positive
306401.0,"Wunderlich Initiates Coverage on Cardiovascular Systems, Inc. at Buy, Announces $24.00 PT",2013-07-26 07:27:00-04:00,CSII,neutral
306402.0,Amended 13D from Discovery on Cardiovascular Systems Shows Stake of 3.5%,2013-05-31 16:21:00-04:00,CSII,neutral
306403.0,"Laidlaw Initiates Coverage on Cardiovascular Systems, Inc. at Buy, Announces $26.00 PT",2013-05-31 08:37:00-04:00,CSII,neutral
306404.0,Cardiovascular Systems Enrolls First Patient in Liberty 360° Study,2013-05-30 10:01:00-04:00,CSII,positive
306405.0,"Cardiovascular Systems Announces Orbit II Evaluating Atherectomy Technology, Met Primary Endpoint",2013-05-23 10:02:00-04:00,CSII,neutral
306406.0,"Cardiovascular Systems, Inc. Sees Q1 EPS $(0.31)-(0.28) vs $(0.30) Est; Sees Sales $26.70M-27.70M vs $27.04M Est",2013-05-01 16:08:00-04:00,CSII,neutral
306407.0,"Cardiovascular Systems, Inc. Reports Q3 EPS of $(0.29) vs $(0.32) Est; Revenue of $26.50M vs $26.02M Est",2013-05-01 16:07:00-04:00,CSII,neutral
306408.0,Cardiovascular Systems Prices 2M Share Public Offering of Common Stock at $17.60 per Share,2013-03-20 08:01:00-04:00,CSII,positive
306409.0,Cardiovascular Systems Announces Public Offering of Common Stock,2013-03-19 16:00:00-04:00,CSII,neutral
306410.0,UPDATE: Benchmark Raises PT on Cardiovascular Systems on Fiscal 2014 Estimates,2013-03-15 08:48:00-04:00,CSII,neutral
306411.0,Cardiovascular Systems Completes PMA Submission of Orbital Atherectomy System for Coronary Artery Disease Treatment ,2013-03-15 08:01:00-04:00,CSII,neutral
306412.0,"Benchmark Maintains Speculative Buy on Cardiovascular Systems, Inc., Raises PT to $24.00",2013-03-15 07:58:00-04:00,CSII,positive
306413.0,Benzinga's Volume Movers,2013-03-11 11:31:00-04:00,CSII,neutral
306414.0,"Cardiovascular Systems Presents Reults at ACC, Says Orbit II Met Primary Endpoints",2013-03-11 08:28:00-04:00,CSII,neutral
306415.0,"Cardiovascular Systems, Inc. Reports Q2 EPS of $(0.28) vs $(0.31) Est; Revenue of $25.30M vs $23.70M Est",2013-01-30 16:01:00-05:00,CSII,neutral
306416.0,Cardiovascular Systems Unveils Late-Breaking Confirmation Series Data at ISET Conference,2013-01-16 08:07:00-05:00,CSII,neutral
306417.0,Discovery Group Showing 6.4% Stake in Cardiovascular Group,2012-12-21 16:46:00-05:00,CSII,neutral
306418.0,UPDATE: Benchmark Raises PT to $18 on Cardiovascular Systems on Improved Visibility   ,2012-12-18 14:03:00-05:00,CSII,positive
306419.0,Stocks Hitting 52-Week Highs,2012-11-05 10:07:00-05:00,CSII,neutral
306420.0,Cardiovascular Systems Reports Q1 EPS $-0.26 vs $-0.34 Est; Revenues $21.5M vs $21.45M Est,2012-10-30 16:05:00-04:00,CSII,neutral
306421.0,Leerink Swann Initiates Coverage on Cardiovascular Systems at Outperform,2012-09-06 10:15:00-04:00,CSII,neutral
306422.0,Clinically Significant 12-Month Results from Cardiovascular Systems' Calcium 360° Study Published in Journal of Endovascular Therapy,2012-08-30 11:55:00-04:00,CSII,positive
306423.0,"The Benchmark Company Maintains Cardiovascular Systems at Speculative Buy, Lowers PT from $15 to $13.50",2012-08-09 06:42:00-04:00,CSII,neutral
306424.0,"McNicoll Lewis Vlak Suspends Coverage on Cardiovascular Systems, Removes PT",2012-07-18 06:08:00-04:00,CSII,neutral
306425.0,"Cardiovascular Systems Announces Pricing of Public Offering of Common Stock, 1.78M Shares at $9",2012-05-22 09:03:00-04:00,CSII,positive
306426.0,"McNicoll Lewis Vlak Initiates Coverage on Cardiovascular Systems at Buy, Announces PT of $17",2012-05-18 07:04:00-04:00,CSII,neutral
306427.0,"Dougherty & Company Initiates Coverage on Cardiovascular Systems at Buy, Announces PT of $14.5",2012-04-11 13:49:00-04:00,CSII,neutral
306428.0,UPDATE: Benchmark Initiates Coverage on Cardiovascular Systems,2012-03-27 08:05:00-04:00,CSII,neutral
306429.0,"The Benchmark Company Initiates Coverage on Cardiovascular Systems at Speculative Buy, Announces PT of $15",2012-03-27 06:32:00-04:00,CSII,positive
306430.0,Cardiovascular System Sees Q2 EPS ($0.22)-($0.19) vs ($0.18) Est; Revenues $19.5M-$20.5M vs $20.9M Est,2011-11-02 16:52:00-04:00,CSII,neutral
306431.0,Feltl & Company Downgrades Cardiovascular Systems to Buy,2011-10-07 09:14:00-04:00,CSII,neutral
306432.0,Cardiovascular Systems Lowers Q1 Guidance,2011-10-06 16:05:00-04:00,CSII,negative
306433.0,Cardiovascular Systems Spiking Lower on Heavy Volume,2011-08-01 12:23:00-04:00,CSII,negative
306434.0,Cardiovascular Systems Spikes to Fresh 52-Week High,2011-07-22 10:53:00-04:00,CSII,positive
306435.0,Cardiovascular Systems Presents New Acute and Long-Term Data from Three Peripheral Clinical Studies   ,2011-06-06 16:05:00-04:00,CSII,neutral
306436.0,Cardiovascular Systems Receives FDA Approval to Complete Patient Enrollment in ORBIT II Coronary Clinical Trial,2011-05-24 08:02:00-04:00,CSII,positive
306437.0,Cardiovascular Systems' COMPLIANCE 360° Trial Demonstrates Superior Acute Results of the Diamondback 360° over Balloon Angioplasty   ,2011-04-05 10:32:00-04:00,CSII,positive
306438.0,Cardiovascular Systems Receives FDA 510(k) Marketing Clearance for Stealth 360 Orbital PAD System   ,2011-03-17 08:01:00-04:00,CSII,negative
306439.0,Cardiovascular Systems Files Special 510(k) for Stealth 360° Orbital Pad System   ,2011-02-10 16:41:00-05:00,CSII,positive
306440.0,Cardiovascular Systems Reports Q2 EPS of $(0.13) ,2011-02-02 16:14:00-05:00,CSII,neutral
306441.0,Cardiovascular Systems Reports Fiscal 2011 First-Quarter EPS of $(0.28),2010-11-03 16:33:00-04:00,CSII,neutral
306442.0,"Cardiovascular Systems, Inc. to Hold Its Annual Meeting ",2010-09-09 16:09:00-04:00,CSII,neutral
306443.0,"Benzinga’s Top Morning Gainers (UPG, CSII, MEDQ, AMS, PCLN)",2009-11-10 11:12:00-05:00,CSII,positive
